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John Copeland5, Fiona E Matthews6, Carol Brayne1, on behalf of the MRC Cognitive Function and Ageing StudyAbstract
Background: In the general population, the epidemiological relationships between delirium and adverse outcomes
are not well defined. The aims of this study were to: (1) construct an algorithm for the diagnosis of delirium using
the Geriatric Mental State (GMS) examination; (2) test the criterion validity of this algorithm against mortality and
dementia risk; (3) report the age-specific prevalence of delirium as determined by this algorithm.
Methods: Participant and informant data in a randomly weighted subsample of the Cognitive Function and Ageing
Study were taken from a standardized assessment battery. The algorithmic definition of delirium was based on the
DSM-IV classification. Outcomes were: proportional hazard ratios for death; odds ratios of dementia at 2-year
follow-up.
Results: Data from 2197 persons (representative of 13,004) were used, median age 77 years, 64% women. Study-defined
delirium was associated with a new dementia diagnosis at two years (OR 8.82, 95% CI 2.76 to 28.2) and death (HR 1.28,
95% CI 1.03 to 1.60), even after adjustment for acute illness severity. Similar associations were seen for study-defined
subsyndromal delirium. Age-specific prevalence as determined by the algorithm increased with age from 1.8% in the
65-69 year age group to 10.1% in the ≥85 age group (p < 0.01 for trend). For study-defined subsyndromal delirium,
age-specific period prevalence ranged from 8.2% (65-69 years) to 36.1% (≥85 years).
Conclusions: These results demonstrate the possibility of constructing an algorithmic diagnosis for study-defined
delirium using data from the GMS schedule, with predictive criterion validity for mortality and dementia risk. These
are the first population-based analyses able to account prospectively for both illness severity and an earlier study
diagnosis of dementia.
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Delirium is a serious neuropsychiatric syndrome pre-
senting with inattention and global changes in cognition
[1-3]. Delirium arises as a consequence of a neurological
or systemic illness, medications and psychological stress.
It is well-recognized that there is a relationship between
predisposing (ageing, cognitive impairment) and precipi-
tating (illness severity) factors such that in the setting of
multiple (or severe) predisposing factors, fewer (or less
severe) precipitating factors are required [4]. Delirium is
therefore a sensitive marker of acute illness in vulnerable
older people. This association with acute illness has re-
sulted in the vast majority of delirium studies being under-
taken in hospital cohorts [5]. However, this introduces
selection biases as not all persons with delirium may reach
medical attention. In addition, comparisons to pre-morbid
cognitive functions are difficult.
In hospital samples, a common finding is that delirium
contributes to persistent cognitive deficits, independently
of predisposing and precipitating factors [6]. This has also
been reported for subsyndromal delirium, where individ-
uals have one or more of the diagnostic features of de-
lirium [7]. Indeed, any examination of the utility of a
delirium definition should incorporate criterion validity
tests for future dementia. In prospective community co-
hort studies, hospitalization predicts adverse cognitive
outcomes [8-10], though none has been able to specify
if delirium is a key determinant. Delirium is also associ-
ated with increased mortality [11], and this should be
another criterion by which any definition of delirium
should be validated.
The point-prevalence of delirium in the community is
thought to be low (0.7%, 95% CI 0.5 to 1.0 in the popula-
tion aged ≥60 years), though this understanding is based
on a systematic review identifying only three prevalence
estimates in population samples [12]. Furthermore, epi-
demiological studies may under-estimate acute illness
and/or prevalent delirium because people who are unwell
are less likely to be interviewed. However, the period-
prevalence may be higher. The Gerontological Regional
Database (GERDA) study reported that 27% of persons
aged 85 and older in the general population with delirium
in the previous month [13]. This suggests that whole
population samples could potentially investigate delirium
more efficiently if stratified subsamples at higher risk for
cognitive impairment are more intensively studied.
Delirium is clinically defined by application of a psy-
chiatric reference standard such as the Diagnostic and
Statistical Manual (DSM), where the core features are
inattention, altered consciousness, cognitive and/or per-
ceptual disturbance, acute and fluctuating change, in rela-
tion to a general medical condition. Based on this, there
is an opportunity to construct an algorithmic diagnosis
for delirium in population-based cohort studies collectingpsychiatric symptoms. Such an approach is well-established
in dementia, but yet to be systematically applied in delir-
ium, and particularly not in population studies. Accord-
ingly, using data from the population-based Medical
Research Council (MRC) Cognitive Function and Ageing
Study (CFAS) the aims of this study were to: (1) construct
an algorithm for the diagnosis of delirium in population-
based studies using the Geriatric Mental State (GMS)
examination based on clinical principles; (2) test the pre-
dictive criterion validity of this algorithm against mortality
and dementia risk; (3) report the age-specific prevalence
of delirium as determined by this algorithm.
Methods
Population
Data from the MRC Cognitive Function and Ageing Study
(CFAS) were used in this secondary analysis. The principal
methods for CFAS have previously been reported [14]. In
brief, CFAS was a multi-center study, with sampling from
four urban (Newcastle, Nottingham, Oxford and Liverpool),
and two rural areas (Cambridgeshire and Gwynedd) in the
UK. The present report only concerns the five identical
sites (excluding Liverpool). Each center had ethical approval
from the Local Research Ethics Committee (Cambridge:
North West Anglia Health Authority Local Research
Ethics Committee (Peterborough); Huntingdon Local
Research Ethics Committee; Cambridge Local Research
Ethics Committee. Gwynedd: Gwynedd Hospitals NHS
Trust – NWHA Research Ethics Committee (West).
Newcastle: Newcastle & North Tyneside Health Author-
ity – Joint Ethics Committee; Northumberland and
Tyne & Wear Health Authority – Local Research Ethics
Committee. Nottingham: QMC NHS Trust Ethics Com-
mittee; Nottingham University Medical School Ethical
Committee; City Hospital Ethics Committee. Oxford:
Oxfordshire Health Authority: Central Oxford Research
Ethics Committee). Family Health Service Authority
lists were used as the sampling frame within a defined
geographical area, and this specifically included people
resident in institutions. Each individual gave written con-
sent to participate in the study.
Figure 1 shows the two stage sampling process for case
ascertainment. A screening examination was started in
1991 (“Screen”, n = 13004)a. Then, a stratified sample
consisted of approximately 20% was selected using center,
age (equal numbers aged 65–74 and ≥75), and cognitive
ability (weighted toward the more cognitively impaired,
based on the screening assessment), and a random sub-
sample from the remaining 80% (“Ascertain”, n = 2640)
(mean interval between “Screen” and “Ascertain” was 3
months). Interviews of participants’ nearest informants
were also undertaken (“Informant”, n = 2159) (mean inter-
val between “Ascertain” and “Informant” was 3 weeks). Par-
ticipants were followed at two years, with further subsets
Figure 1 Assessment and follow-up schedule for the first two
years of CFAS. Schematic showing the numbers assessed, along
with informant histories, both at baseline and follow-up. In the text,
S0; A0; H0; C2 are described as “Screen”; “Ascertainment”; “Informant”;
“Follow-up” respectively.
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examined at 6 and 10 years. The number of participants at
baseline and at the first two-year follow-up is shown in
Figure 1. Mortality outcomes were notified through re-
ports linked to the UK Office of National Statistics.
Interviews
Interviews were carried out in participants’ usual residence
(including if in a care home) by trained interviewers. At
screening, information on socio-demographic, physical
and behavioral status was collected in addition to health
(including self-reported chronic conditions) and cognitive
function, assessed using the MMSE. The assessment inter-
view was based on the GMS [15], which was designed to
be a structured schedule amenable to administration by
non-clinicians. The GMS comprises measures assessing
psychiatric symptoms of organicity, depression, anxiety
and psychosis, with ratings for each derived using the
AGECAT algorithm. The study diagnosis of dementia was
based on the GMS B3 AGECAT algorithmic differential
diagnosis, where the dementia component is organicity at
case level 03 and above. This approach has been validated
against formal clinical diagnoses based on DSM-III-R [16].Table 1 The prevalence of delirium symptom clusters at base
Symptom Interview question (yes/no)
Acute change Has there been sudden worsening in mental confusio
continued to the present time?
Fluctuation Are there episodes lasting days or weeks when his/her th
Are there long periods during the day when s/he is lu
is and knows what s/he is doing and saying)?
Does s/he get confused at night, wander about or talk
Or at any other time? What about during the day time
Inattention Impaired ability to focus sustain and shift attention
Drowsiness Disturbance of consciousness, that is either being slee
Is the subject drowsy now?
Delirium judgment Could a physical illness (not drugs or alcohol intoxicat
subject's mental or psychiatric symptoms (e.g. deliriou
*Question comes from prevalence assessment “Ascertain”, denominator = 2640, all o
A symptom was scored as ‘present’ if a positive response was given to one or more
Inattention assessed by examination of participant with serial 7s task or counting bAll information was based on self-report. Informant prox-
ies were also interviewed in a standardized manner using a
set of questions complementary to the GMS known as the
History and Aetiology Schedule (HAS). Informants were
asked questions covering psychiatric symptom clusters
occurring in ‘recent weeks and months’. Each inter-
viewer for “Follow-up” undertook assessments blinded
to data acquired in the baseline phase.
Questions from “Ascertain” and “Informant” (Figure 1)
pertaining to delirium symptoms are shown in Table 1.
These were used to define an algorithm for a study def-
inition of delirium based on DSM-IV, where participants
were required to demonstrate all three of: (i) acute
change; (ii) fluctuation; (iii) inattention and/or drowsi-
ness (Table 2). Subsyndromal delirium was defined as
having at least one of these features. In addition, inter-
viewers were asked to judge if responses were affected
by their subjective rating of any current acute illness in
the participants (categorized as: none, mild, moderate,
or severe).
Statistical analyses
The criterion validity of the study-defined delirium algo-
rithm was tested in two ways: (i) hazard for mortality
and (ii) odds of a new diagnosis of dementia at two year
follow-up. The association between study-defined delir-
ium and mortality was evaluated using Cox proportional
hazards models, adjusted by age, sex and prevalent demen-
tia. The association between study-defined delirium and
dementia was assessed using logistic regression where
the outcome was new dementia at two-year follow-up
(“Follow-up”, Figure 1) in the sample known to be
dementia-free at baseline, adjusted by age and sex
(“Ascertain”, Figure 1). Each delirium symptom was
tested for both outcomes, as well as the overall algo-
rithmic diagnosis. Testing the criterion validity of theline
N (2197) %
n in recent weeks or months, which has 199 9.1%
inking seems quite clear and then becomes muddled? 264 12.0%
cid and not confused (that is, knows where s/he
nonsense?
?
230 8.7%*
py, or awake but unaware of their surroundings 142 6.5%
ion) be sufficient explanation for the
s due to acute infection)?
34 1.6%
ther questions from History and Aetiology Schedule (“Informant”).
question in the cluster.
ackwards from 20.
Table 2 Delirium algorithm
Delirium = Informant reporting [Acute change] + [Fluctuation] +
[Inattention and/or drowsiness]
OR
= Interviewer judgment: a physical illness … be sufficient
explanation for the subject's mental or psychiatric symptoms
(e.g. delirious due to acute infection)
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rating of current acute illness severity. Post-estimation
tests for underlying assumptions included Hosmer-
Lemershow goodness-of-fit and Schoenfeld residuals for
logistic and proportional hazards models respectively.
Results
The subsample selected for this analysis included 2197
individuals assessed by both the GMS (participant) and
HAS (informant) schedules at the assessment interview
(“Ascertain”). Median age was 77 (interquartile range
71-84), and 1403 (64%) were women. In this weighted
subsample of the whole baseline cohort, 511 (23%) had
prevalent dementia. Table 1 lists the delirium symptom
clusters and questions used to ascertain these, along with
the prevalence of individual symptoms. Table 3 reports
the age and sex characteristics of the sample, number of
persons with study-defined delirium and dementia, and
incident dementia and mortality at two years.
Table 4 shows the results of the Cox proportional haz-
ards survival analyses, adjusted by age, sex and prevalent
dementia. In this weighted subsample, each delirium symp-
tom was independently associated with higher mortality.
This was also the case for the algorithmic diagnosis, even
after adjustment for acute illness severity (HR 1.28, 95% CI
1.03 to 1.60). A similar risk for study-defined subsyndromal
delirium was apparent (HR 1.41, 95% CI 1.23 to 1.62).Table 3 Cases of study-defined delirium and dementia, with o
Age (median, IQR)
Sex (n women, %)
Dementias at baseline Cases
Denominator
Missing
Death within two-year interval Cases
Denominator
Missing
Incident dementia at follow-up two years later Cases
Denominator
Missing (not including d
Groups described here are from the assessed population, i.e. 20% most cognitively
Delirium, as defined through study algorithm.
IQR interquartile range.
Dementia diagnoses from AGECAT.Table 5 gives the results of the logistic regression ana-
lyses assessing the odds of a dementia diagnosis at two
year follow-up, adjusted by age and sex. In this weighted
subsample, all delirium symptoms were associated with
odds ratios greater than 1.0, but this was only statistically
significant for acute change, fluctuation and drowsiness.
The algorithmic diagnosis was significantly associated
with a two year dementia diagnosis (OR 8.82, 95% CI 2.76
to 28.2). The estimate for study-defined subsyndromal de-
lirium was half that of full syndromal delirium (OR 4.31,
95% CI 2.41 to 7.73).
The estimated age-specific period prevalence of the al-
gorithmic diagnosis of delirium is given in Figure 2. The
overall period prevalence in this subsample of enriched
for cognitive impairment is estimated at 5.6% (95% CI 4.6
to 6.5). Age-specific prevalence increases with age from
1.8% in the 65-69 year age group to 10.1% in the ≥85 age
group (p < 0.01 for trend). For study-defined subsyndro-
mal delirium, age-specific period prevalence ranged from
8.2% (65-69 years) to 36.1% (≥85 years). In persons with
prevalent dementia, 16.8% (95% CI 13.6 to 20.1%) had
superimposed delirium.
Discussion
These results demonstrate the possibility of constructing
an algorithmic diagnosis for delirium within a population-
based framework using data from the GMS schedule
including self and informant reported responses. This al-
gorithm has criterion validity for mortality and dementia
risk. These are the first population-based analyses able to
account for both illness severity and prevalent dementia,
suggesting that our study-defined delirium has a deleteri-
ous effect on mortality and dementia risk beyond that ex-
pected from precipitating and predisposing factors alone.
These findings also highlight the importance of age in theutcomes at two years later
No delirium (n = 2075) Delirium (n = 122)
76.8 (70.8 – 83.5) 83.2 (75.4 – 87.7)
1316 (63) 87 (71)
425 21% 86 72%
2065 119
10 3
706 34% 72 61%
2065 119
10 3
102 9% 9 45%
1129 20
eaths) 240 27
impaired at screen, plus random sample of remainder.
Table 4 Survival models for study-defined delirium
N Missing data HR LCI UCI P
Delirium symptom clusters
Inattention 2637 3 1.36 1.16 1.58 <0.01
Acute change 2184 13 1.57 1.33 1.85 <0.01
Fluctuation 2184 13 1.40 1.21 1.62 <0.01
Drowsiness 2184 13 1.31 1.08 1.57 <0.01
Judged delirium* 2184 13 1.92 1.35 2.74 <0.01
Delirium: final model 2159 38
Delirium 1.28 1.03 1.60 0.03
Dementia 1.83 1.63 2.06 <0.01
Age (per year) 1.08 1.08 1.09 <0.01
Sex (women versus men) 0.68 0.61 0.75 <0.01
Illness severity
None [Ref]
Mild 1.47 1.15 1.88 <0.01
Moderate 1.52 1.10 2.12 <0.01
Severe 3.14 2.23 4.42 <0.01
Subsyndromal delirium: final model 2159 38
Sybsyndromal delirium 1.41 1.23 1.62 <0.01
Dementia 1.62 1.42 1.85 <0.01
Age (per year) 1.08 1.07 1.09 <0.01
Sex (women versus men) 0.67 0.61 0.75 <0.01
Illness severity
None [Ref]
Mild 1.32 1.03 1.70 0.03
Moderate 1.50 1.10 2.06 0.01
Severe 2.94 2.10 4.12 <0.01
HR hazard ratio, LCI UCI 95% lower and upper confidence intervals respectively.
This table shows Cox proportional hazard models for death.
“Delirium symptom clusters” shows individual symptom clusters, and their association with mortality (adjusted for age, sex, baseline dementia and illness severity),
i.e. the independent effects of each symptom cluster.
*‘Judged delirium’ refers to the overall impression of the interviewer that a participant had delirium.
“Delirium: final model” refers to the full model for full syndromal delirium and the same adjusted covariates.
“Subsyndromal delirium: final model” describes the full model for subsyndromal delirium and the same adjusted covariates.
Missing data. These arise through non-responses in interviewed participants or respondents. Estimated models are based on complete cases, i.e. where all
covariates are complete for the sample.
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oldest-old group (i.e. ≥85 years).
The strengths of this study derive from its large
population-based sample size and availability of serial
cognitive assessments in relation to incident dementia.
The major limitation is that the algorithm was not vali-
dated with concurrent clinical diagnosis of delirium. Fur-
thermore, the period over which informants were asked to
comment on delirium symptoms was not strictly defined
(‘in recent weeks and months’) and may be overstated due
to recall bias. The lack of assessments by clinicians also
limits the precision of the data. Though dementia as a bin-
ary predisposing factor in delirium is a well-established
construct, delirium could be associated with mild orminimal dementia-type states not captured by the AGE-
CAT diagnosis. Analyses taking the continuum of cogni-
tion into account would address this concern to some
extent, though there is real difficulty in disentangling such
closely associated phenomena, both in clinical and epi-
demiological studies. Nonetheless, this does not detract
from the prognostic significance of delirium symptoms for
future dementia. As with any observational study, both
over-adjustment and residual confounding remain consid-
erations. It is recognized that the effect of age on total de-
mentia risk is so large that it overshadows many of other
associations under investigation (particularly modifiable
risk factors) [17,18]. This has been specifically observed in
previous CFAS analyses [19,20], and therefore it is not
Table 5 Logistic models for two year dementia
N Missing data OR LCI UCI P
Delirium symptom clusters
Inattention 1347 37 1.90 0.77 4.69 0.16
Acute change 1149 235 7.63 3.47 16.75 <0.01
Fluctuation 1347 37 6.84 3.67 12.77 <0.01
Drowsiness 1347 37 4.83 2.50 9.35 <0.01
Judged delirium* 1149 235 4.44 0.78 25.26 0.09
Delirium: final model 1140 244
Delirium 8.82 2.76 28.2 <0.01
Age (per year) 1.11 1.08 1.14 <0.01
Sex (women versus men) 0.96 0.61 1.50 0.85
Illness severity
None [Ref]
Mild 1.66 0.57 4.79 0.35
Moderate 1.41 0.31 6.37 0.66
Severe (omitted)**
Subsyndromal delirium: final model 1140 244
Subsyndromal delirium 4.31 2.41 7.73 <0.01
Age (per year) 1.10 1.07 1.14 <0.01
Sex (women versus men) 0.94 0.60 1.47 0.78
Illness severity
None [Ref]
Mild 1.02 0.35 2.95 0.98
Moderate 1.54 0.41 5.77 0.52
Severe (omitted)**
OR odds ratio, LCI UCI 95% lower and upper confidence intervals respectively.
This table shows logistic regression models for dementia at two year follow-up.
“Delirium symptom clusters” shows individual symptom clusters, and their association with dementia (adjusted for age, sex, baseline dementia and illness
severity), i.e. the independent effects of each symptom cluster.
*‘Judged delirium’ refers to the overall impression of the interviewer that a participant had delirium.
“Delirium: final model” refers to the full model for full syndromal delirium and the same adjusted covariates.
“Subsyndromal delirium: final model” describes the full model for subsyndromal delirium and the same adjusted covariates.
**The effect of severe illness was not estimated due to no participants being assigned to this category.
Missing data. These arise through non-responses in interviewed participants or respondents. There were also losses to follow-up that did not include death
(n = 267). Estimated models are based on complete cases, i.e. where all covariates are complete for the sample.
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in dementia risk models. Finally, though the CFAS sample
was population-representative in 1991, the age-specific
prevalence of dementia is lower in 2011 [21] and so
secular trends may constrain the accuracy of the delir-
ium prevalence estimates.
The estimated age-specific population prevalence of
study-defined delirium is lower than the only other estimate
available (from GERDA), even though diagnoses included
information from community medical records [13]. Previ-
ously, the only population-based cohort to have assessed a
delirium measure in relation to adverse outcomes is the
Vantaa 85+ study [22,23]. In Vantaa 85+, delirium history
was assessed at each interview by a neurologist with access
to an informant and medical records, amounting to anestimate of period prevalence for the intervening 2-3 years
between waves. The present analysis is four times bigger
(CFAS = 2197 versus Vantaa = 553). Though medical re-
cords were not available here, the advantage in CFAS is
the possibility of accounting for illness severity, even though
this assessment was subjective. The point estimates for
mortality (CFAS HR 1.55 (when unadjusted by illness se-
verity) versus Vantaa HR 1.61) and two-year dementia risk
(CFAS OR 8.82 versus Vantaa OR 8.65) are effectively the
same. Though delirium diagnoses were derived through
different approaches, this suggests the core features of in-
attention, altered arousal (here characterized as ‘drowsi-
ness’) and acute fluctuations in cognitive function represent
an adverse state for future outcomes regardless of the
exact methods for operationalizing the syndrome.
Figure 2 Prevalence of study-defined delirium and subsyndromal
delirium, by age group. Bar chart showing estimated age-specific
prevalence of the algorithm diagnosis of delirium (grey) and subsyndromal
delirium (dark grey) as a proportion of the assessed subsample. Upper
and lower bars show 95% confidence intervals.
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These data add to the small literature on the population-
based epidemiology of delirium. Delirium, as defined in
this study, is associated with increased dementia, strength-
ening the argument that interventions for delirium may
have an impact on the burden of cognitive impairment.
Nonetheless, the core elements of the delirium-dementia
relationship still require further exploration (e.g. if the key
factors responsible for this association relate to etiology,
duration, severity or some combination), particularly in
the general population and in other cohort studies [18].
At the least, these findings indicate that it is possible to
identify population samples with delirium and subsyndro-
mal delirium at higher risk for dementia.
Endnote
aIn other CFAS publications, the stages: S0; A0; H0; C2 are
described here as “Screen”; “Ascertainment”; “Informant”;
“Follow-up” respectively.
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